The proportion of total LAG-3+ cells was twice higher in cHL (6% of total cells) than in non-GCB (3% of total cells) and GCB DLBCL (1% of total cells) (p ≤ 0.0001) (Figure 3C and Figure 4E). This evidence concerns the gene LAG3 and diffuse large B-cell lymphoma.